Physician
Zipclinic, PSC
Zipclinic, PSC was paid $4.45M by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoZIPCLINIC, PSC
BOWLING GREEN, KY 42104
BOWLING GREEN, KY 42104
33aNPI1861873507assigned 06/17/2015
33bProvider typeGeneral Practice Physician
28Total paid$4.45M
24GClaims184,877
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Kentucky
Rank by total paid#1 of 25
Median peer was paid$50K
This provider vs. median90×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,358 | $532K | |
| 2019 | 21,776 | $665K | |
| 2020 | 23,652 | $510K | |
| 2021 | 30,965 | $573K | |
| 2022 | 31,634 | $795K | |
| 2023 | 35,799 | $838K | |
| 2024incomplete | 24,693 | $538K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 40,944 | 33,809 | $1.52M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 17% | 19,952 | 15,772 | $762K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 27,714 | 22,991 | $663K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 13% | 20,966 | 17,198 | $574K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.9% | 31,939 | 13,965 | $309K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.5% | 5,450 | 4,090 | $292K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.7% | 16,698 | 14,624 | $165K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 5,345 | 4,237 | $60K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 5,821 | 3,196 | $48K |
| 87428 | <1% | 1,009 | 665 | $27K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 743 | 474 | $12K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,540 | 2,092 | $4K |
24 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 408 | $4K |
| 87807 | <1% | 302 | $2K | |
| 99201 | <1% | 182 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 191 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 36 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 50 | $1K |
| 90688 | <1% | 109 | $980.78 | |
| 90756 | <1% | 60 | $827.88 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 98 | $825.19 |
| 99383 | <1% | 29 | $651.80 | |
| 99384 | <1% | 18 | $647.82 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 97 | $348.90 |
| 86580 | <1% | 58 | $235.85 | |
| 90686 | <1% | 13 | $216.23 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 30 | $189.76 |
| 81002 | <1% | 508 | $186.49 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $178.43 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $178.43 |
| 81003 | <1% | 921 | $174.88 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 61 | $149.67 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 28 | $120.48 |
| 99000 | <1% | 2,473 | $84.25 | |
| 99429 | <1% | 37 | $13.50 | |
| 99499 | <1% | 19 | $6.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKNORR, MICHELE (SR CONTRACTING & CREDENTIALING SPEC)